LRP1 and acute kidney injury: Furthermore, our study demonstrates that inhibiting renal MDK expression alleviates cognitive impairment and reduces microglial activation, highlighting the therapeutic potential of targeting the MDK‐LRP1 pathway in AKI‐related cognitive decline.